Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Human Alfa Fund was established to enhance the commercialization of technology by integrating technical knowledge with humanistic values. Based in Poland, it operates through two entities: Jagiellońskie Centrum Innowacji Sp. z o.o. and Aktywator Innowacji Sp. z o.o.. The organization has extensive experience in investment activities focused on advanced technologies that support health and improve the quality of life. As of January 30, 2023, the fund's investment activities have concluded, marking a significant shift in its operational strategy.
Human Alfa Fund has gained recognition for its unique approach, winning 1st place among applicants in the Bridge Alfa program, a Polish government co-investment initiative. This program provides public funding to seed-stage VC funds that back early-stage technology companies, indicating that Human Alfa Fund is at least partially government-backed. The firm has a portfolio of completed projects aimed at promoting health and enhancing human comfort, reflecting its commitment to integrating humanistic values with technology.
Human Alfa Fund invests in advanced technologies that promote health and enhance human comfort, with a strong emphasis on the importance of human roles within the Earth's ecosystem. The fund primarily targets the seed stage in the healthcare and biotech sectors, focusing on innovations that align with its mission of improving quality of life. The firm’s investment strategy is characterized by its interdisciplinary approach, integrating technical knowledge with humanistic values.
The fund's investment thesis highlights the significance of sustainability in the ecosystem, aiming to support projects that not only advance technology but also consider the broader implications for human well-being. Human Alfa Fund seeks to engage with founders who share a vision of enhancing health and comfort through innovative solutions, emphasizing the need for a strong alignment of values between the fund and its portfolio companies.
Human Alfa Fund has a portfolio of completed projects that reflect its focus on health and human comfort. However, specific names of portfolio companies have not been disclosed. The fund's emphasis on advanced technologies in healthcare and biotech suggests that its past investments likely include innovative startups in these sectors. The organization’s commitment to integrating humanistic values with technology commercialization has guided its investment decisions, although detailed outcomes of these projects remain unspecified.
As the fund has concluded its investment activities, it is important to note that while there are no current portfolio companies, the completed projects may provide insights into the types of innovations the fund has supported in the past. Engaging with Human Alfa Fund could yield valuable information about its previous investments and the impact they have had on the healthcare and biotech sectors.
Paweł Błachno - President, Investment Director. He has extensive experience in investment activities and leads the strategic direction of the fund.
Michał Latacz - Board Member, CTO. He brings technical expertise to the fund, focusing on the evaluation of technology projects.
Włodzimierz Laskowski - Investment Manager. He is responsible for managing the fund's investment portfolio and identifying new opportunities.
Dr. Anita Burkat–Dulak - R&D Portfolio Manager. She oversees research and development initiatives within the fund's portfolio, ensuring alignment with health-focused projects.
Konrad Gliściński, LL.M - IP Manager, Lawyer. He provides legal expertise, particularly in intellectual property matters related to the fund's investments.
To pitch to Human Alfa Fund, founders should visit their website at humanalfa.com. While specific details regarding the preferred channel for pitches are not provided, the website serves as the main point of contact. Founders should include a clear articulation of their project's alignment with the fund's focus on health and human comfort in their pitch deck.
It is advisable to outline the sustainability aspects of the project and how it integrates humanistic values with technology. Response times for pitches are not specified, so founders should be prepared for varying timelines.
As of January 30, 2023, Human Alfa Fund has concluded its investment activities, indicating a significant shift away from active engagement in the venture capital space. No recent blog activity or updates have been detected since this conclusion.
Prior to this, the fund was recognized for its unique approach to integrating humanistic values with technology commercialization, particularly in the healthcare and biotech sectors.
What are Human Alfa Fund's investment criteria?
The fund focuses on advanced technologies that promote health and enhance human comfort, primarily in the healthcare and biotech sectors. It invests at the seed stage and looks for projects that align with its mission of integrating humanistic values with technology.
How can I apply or pitch to Human Alfa Fund?
For pitches or applications, founders are encouraged to visit the fund's website at humanalfa.com. Specific details regarding the application process are not publicly available, but the website serves as the primary contact point.
What makes Human Alfa Fund different from other VCs?
Human Alfa Fund distinguishes itself by integrating humanistic values with technology commercialization. This unique approach emphasizes the importance of sustainability and the human role within the ecosystem, which is not commonly prioritized in traditional venture capital.
What is the geographic scope of Human Alfa Fund's investments?
The fund primarily focuses on investments within Europe, particularly in Poland, where it is based. This geographic emphasis allows it to leverage local knowledge and networks in the healthcare and biotech sectors.
What kind of support does Human Alfa Fund provide post-investment?
While specific details about post-investment involvement are not disclosed, the fund offers support in areas such as international VC relations, M&A advisory, exit strategy, and commercialization strategy, which can be beneficial for portfolio companies.
What is the fund size and check size for investments?
Human Alfa Fund has not disclosed specific quantitative metrics such as fund size or check sizes for investments. However, it is known to operate primarily at the seed stage.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.